Microbot Medical shares up 10.33% intraday as Emory University Hospital adopts LIBERTY® robotic system, boosting commercialization.

Microbot Medical surged 10.33% intraday, as the company announced Emory University Hospital became the first global adopter of its LIBERTY® Endovascular Robotic System, accelerating commercialization. The company specializes in robotic minimally invasive surgical devices, with LIBERTY being the first FDA-cleared single-use remotely operated vascular robot. Additionally, HC Wainwright & Co. reiterated a "Buy" rating with a $12 price target.